Torrent Pharma has launched the most effective and safe COX 2, valdecoxib, under the brand name of Valz BCD in the pain management segment. Valz BCD is the world’s first combination of valdecoxib and betacyclodextrin. The ‘BCD inclusion complex’ drug delivery system ensures a faster rate of drug absorption as compared to conventional tablets.

Valz BCD has been well accepted by doctor community due to its attributes of instant pain relief, superior analgesia (pain relief) and no alimentary side effects as compared with existing NSAIDs like diclofenac and nimesulide. Valdecoxib is the fastest growing molecule in the Rs. 900 crore pain market and is likely to become a Rs. 100 crore molecule by this year end. Valz BCD is expected to touch a sale in excess of Rs. 15 crore by the end of this fiscal, stated a company release.

Developed indigenously at the state-of-the-art Torrent Research Centre, Valz BCD has not only opened new vistas in the treatment of pain, but also fulfilled the much-needed demand for a fast, effective and safe analgesia in pain management.

To offer superior and complete pain management solutions, Torrent has also added to its kitty Parecoxib Injection, the world’s first COX 2 injectable under the brand name of Valz Inj. This not only outscores the existing injectable NSAIDs on GI safety but also on its superior analgesia and quick action time of seven minutes. Its morphine sparing effect and low effect on platelet aggregation makes it a unanimous choice in critical surgeries.